M Schild1, M Meurer2. 1. Klinik und Poliklinik für Dermatologie, Universitätsklinikum Carl Gustav Carus, Dresden, Deutschland. 2. Stiftung zur Förderung der Hochschulmedizin in Dresden, Fetscherstraße 74, 01307, Dresden, Deutschland. michael.meurer@uniklinikum-dresden.de.
Abstract
BACKGROUND: Vitiligo is a chronic skin disorder with depigmentation of circumscribed areas due to structural and functional damage to melanocytes. RESULTS: There is international consensus on the classification in nonsegmental and segmental vitiligo. The influence of vitiligo on the quality of life is significant and is influenced by ethnic and sociocultural factors. There is a new insight into the genetic susceptibility, mechanisms and targets of the autoimmune inflammation, the altered morphology and function of melanocytes and into the association of vitiligo with other autoimmune diseases, skin cancer and skin cancer therapy. CONCLUSIONS: The recognition of associated autoimmune disorders is as important as is the assessment of changes in the quality of life. New insight into the pathogenesis may have therapeutic consequences. The relationship between vitiligo and skin cancer and between vitiligo and immunotherapies in patients with metastatic melanoma warrants close clinical monitoring of affected patients and further scientific studies.
BACKGROUND:Vitiligo is a chronic skin disorder with depigmentation of circumscribed areas due to structural and functional damage to melanocytes. RESULTS: There is international consensus on the classification in nonsegmental and segmental vitiligo. The influence of vitiligo on the quality of life is significant and is influenced by ethnic and sociocultural factors. There is a new insight into the genetic susceptibility, mechanisms and targets of the autoimmune inflammation, the altered morphology and function of melanocytes and into the association of vitiligo with other autoimmune diseases, skin cancer and skin cancer therapy. CONCLUSIONS: The recognition of associated autoimmune disorders is as important as is the assessment of changes in the quality of life. New insight into the pathogenesis may have therapeutic consequences. The relationship between vitiligo and skin cancer and between vitiligo and immunotherapies in patients with metastatic melanoma warrants close clinical monitoring of affected patients and further scientific studies.
Entities:
Keywords:
Autoimmune diseases; Diagnostic workup; Differential diagnoses; Quality of life; Skin cancer
Authors: A Taieb; A Alomar; M Böhm; M L Dell'anna; A De Pase; V Eleftheriadou; K Ezzedine; Y Gauthier; D J Gawkrodger; T Jouary; G Leone; S Moretti; L Nieuweboer-Krobotova; M J Olsson; D Parsad; T Passeron; A Tanew; W van der Veen; N van Geel; M Whitton; A Wolkerstorfer; M Picardo Journal: Br J Dermatol Date: 2012-11-02 Impact factor: 9.302
Authors: K C Meyer; J E Klatte; H V Dinh; M J Harries; K Reithmayer; W Meyer; R Sinclair; R Paus Journal: Br J Dermatol Date: 2008-09-15 Impact factor: 9.302
Authors: Camile L Hexsel; Melody J Eide; Christine C Johnson; Richard Krajenta; Gordon Jacobsen; Iltefat Hamzavi; Henry W Lim Journal: J Am Acad Dermatol Date: 2009-04-17 Impact factor: 11.527
Authors: Mohamed M A E L Salem; Mohammad Shalbaf; Nicholas C J Gibbons; Bhaven Chavan; J M Thornton; Karin U Schallreuter Journal: FASEB J Date: 2009-07-29 Impact factor: 5.191